Open Access
BIO Web Conf.
Volume 59, 2023
2023 5th International Conference on Biotechnology and Biomedicine (ICBB 2023)
Article Number 02003
Number of page(s) 7
Section Precision Medicine and Drug Development and Preparation
Published online 08 May 2023
  • Ishino Y., Shinagawa H., Makino K., Amemura M., Nakata A.: Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. Journal of Bacteriology 1987, 169(12):5429–5433. [CrossRef] [PubMed] [Google Scholar]
  • Larson M.H., Gilbert L.A., Wang X., Lim W.A., Weissman J.S., Qi L.S.: CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nature Protocols 2013, 8(11):2180–2196. [CrossRef] [PubMed] [Google Scholar]
  • Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F.: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians 2021, 71(3):209–249. [CrossRef] [PubMed] [Google Scholar]
  • Freddie, Bray, Jacques, Ferlay, Isabelle, Soerjomataram, Rebecca, Siegel, Lindsey: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2018. [PubMed] [Google Scholar]
  • Mcmillan N.A.J., Jubair L., Fallaha S.: Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors. Molecular therapy: the journal of the American Society of Gene Therapy 2019(27–12). [Google Scholar]
  • Ehrke-Schulz E., Heinemann S., Schulte L., Schiwon M., Ehrhardt A.: Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill HumanPapillomavirus-Induced Cervical Cancer Cells. Cancers 2020, 12(7):1934. [CrossRef] [PubMed] [Google Scholar]
  • Zhen S., Lu J.J., Wang L.J., Sun X.M., Zhang J.Q., Li X., Luo W.J., Zhao L.: In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line. Translational Oncology 2016, 9(6):498–504. [CrossRef] [PubMed] [Google Scholar]
  • Zhen S., Li X.: Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer. Cellular Physiology and Biochemistry 2017, 44(6):2455–2466. [CrossRef] [PubMed] [Google Scholar]
  • Kaminski R., Chen Y., Fischer T., Tedaldi E., Napoli A., Zhang Y., Karn J., Hu W., Khalili K.: Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR/Cas9 gene editing. Scientific reports 2016, 6(1):1–15. [CrossRef] [Google Scholar]
  • Liao H.K., Gu Y., Diaz A., Marlett J., Takahashi Y., Li M., Suzuki K., Xu R., Hishida T., Chang C.-J.: Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells. Nature communications 2015, 6(1):1–10. [Google Scholar]
  • Nahmad A.D., Lazzarotto C.R., Zelikson N., Kustin T., Barzel A.: In vivo engineered B cells retain memory and secrete high titers of anti-HIV antibodies in mice. Cold Spring Harbor Laboratory 2021. [Google Scholar]
  • Taylor M.M., Wi T., Gerbase A., Thwin S.S., Gottlieb S., Babovic M.T., Low-Beer D., Alonso M., Mello M.B., Ishikawa N.: Assessment of country implementation of the WHO global health sector strategy on sexually transmitted infections (2016-2021). PloS one 2022, 17(5):e0263550. [CrossRef] [PubMed] [Google Scholar]
  • Ramanan V., Shlomai A., Cox D., Schwartz R.E., Bhatia SN: CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus. Scientific Reports 2015, 5:10833. [CrossRef] [PubMed] [Google Scholar]
  • Jiang C., Mei M., Li B., Zhu X., Zu W., Tian Y., Wang Q., Guo Y., Dong Y., Tan X.: A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo. Cell research 2017, 27(3):440–443. [CrossRef] [PubMed] [Google Scholar]
  • Li B., Luo X., Deng B., Wang J., McComb D.W., Shi Y., Gaensler K.M., Tan X., Dunn A.L., Kerlin B.A.: An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo. Nano letters 2015, 15(12):8099–8107. [CrossRef] [PubMed] [Google Scholar]
  • Blanchard E.L., Vanover D., Bawage S.S., Tiwari P.M., Santangelo PJ: Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents. Nature Biotechnology 2021. [PubMed] [Google Scholar]
  • Cui Z., Zeng C., Huang F., Yuan F., Yan J., Zhao Y., Zhou Y., Hankey W., Jin V.X., Huang J.: Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection. Nature Chemical Biology 2022:1–9. [Google Scholar]
  • East-Seletsky A., O'Connell M.R., Knight S.C., Burstein, D., Cate J.H.D., Tjian, R., Doudna J.A.: Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature 2016, 538(7624):270–273. [CrossRef] [PubMed] [Google Scholar]
  • Chen J.S., Ma E., Harrington L.B., Costa M., Tian X., Palefsky J.M., Doudna J.A.: CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science 2018, 360(6387):eaar6245. [Google Scholar]
  • Curti L.A., Primost I., Valla S., Alegre D.I., Marcone D.N.: Evaluation of a Lyophilized CRISPR-Cas12 Assay for a Sensitive, Specific, and Rapid Detection of SARS-CoV-2. Viruses 2021, 13(3):420. [CrossRef] [PubMed] [Google Scholar]
  • Chen P., Chen M., Chen Y., Jing X., Zhang N., Zhou X., Li X., Long G., Hao P.: Targeted inhibition of Zika virus infection in human cells by CRISPR-Cas13b. Virus Research 2022, 312:198707. [CrossRef] [PubMed] [Google Scholar]
  • Kim D.Y., Lee J.M., Su B.M., Chin H.J., Kim Y.S.: Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus. Nature Biotechnology 2021:1–9. [PubMed] [Google Scholar]
  • Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell 2014, 159(3). [Google Scholar]
  • Ablain J., Durand E., Yang S., Zhou Y., Zon L.: A CRISPR/Cas9 Vector System for Tissue-Specific Gene Disruption in Zebrafish. Developmental Cell 2015, 32(6). [Google Scholar]
  • Swiech L., Heidenreich M., Banerjee A., Habib N., Li Y., Trombetta J., Sur M., Zhang F.: In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nature Biotechnology 2015, 33(1):102–106. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.